We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Corning Inc | NYSE:GLW | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.37 | 1.11% | 33.85 | 33.80 | 33.075 | 33.76 | 5,213,560 | 00:11:24 |
FORM 3
| Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Verkleeren Ronald L |
2. Date of Event Requiring Statement (MM/DD/YYYY)
| 3. Issuer Name and Ticker or Trading Symbol CORNING INC /NY [GLW] |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Senior VP & GM, Life Sciences / | ||
5. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned | |||
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 5448 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Restricted Stock Unit | (1) | (1) | Common Stock | 5087 | (2) | D | |
Restricted Stock Unit | (3) | (3) | Common Stock | 4054 | (2) | D | |
Restricted Stock Unit | (4) | (4) | Common Stock | 8634 | (2) | D | |
Restricted Stock Unit | (5) | (5) | Common Stock | 1525 | (2) | D | |
Restricted Stock Unit | (5) | (5) | Common Stock | 8802 | (2) | D | |
Restricted Stock Unit | (4) | (4) | Common Stock | 3319 | (2) | D | |
Stock Options (Right to Buy) | 4/2/2021 | 4/2/2028 | Common Stock | 9157 | $27.03 | D | |
Stock Options (Right to Buy) | 4/1/2022 | 4/1/2029 | Common Stock | 8107 | $33.92 | D | |
Stock Options (Right to Buy) | (6) | 5/15/2030 | Common Stock | 7625 | $19.65 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Verkleeren Ronald L ONE RIVERFRONT PLAZA CORNING, NY 14831 | Senior VP & GM, Life Sciences |
Signatures | ||
Linda E. Jolly, Power of Attorney | 10/9/2020 | |
**Signature of Reporting Person | Date |
1 Year Corning Chart |
1 Month Corning Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions